Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)

View source ↗

Summary

An observational study evaluating erlotinib (Tarceva) in participants with locally advanced or metastatic non-small cell lung cancer (adenocarcinoma, non-squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Squamous Non-Small Cell Lung Cancer | Status: COMPLETED | Results posted: 2017-05-04